1. Hong Kong Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Modern Dental Group Limited

Modern Dental Group Limited

0.82
EUR
-0.01
(-1.20%)
542.07MMarket Cap
Mar 30Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.19
1.72
1.66
2.19
2.32
2.45
2.28
3.09
2.96
3.33
3.56
3.99
- -
Basic EPS, GAAP
0.12
0.1
0.1
0.16
0.09
0.16
0.11
0.38
0.23
0.42
0.43
0.64
- -
Free Cash Flow per Basic Share
0.16
0.11
0.08
- -
0.06
0.2
0.34
0.4
0.08
0.44
0.39
0.74
- -
Dividend per Share
0.01
0.03
0.02
0.03
0.04
0.04
0.02
0.19
0.08
0.1
0.17
0.2
- -
Book Value per Share
0.54
1.78
1.82
2.1
2
2.09
2.34
2.45
2.43
2.78
2.88
3.52
3.52
Tangible Book Value per Share
-0.32
0.58
0.16
0.31
0.32
0.43
0.75
0.95
1
1.33
1.5
1.75
1.75
Basic Weighted Avg Shares
1,000
825
992
996
997
980
962
957
956
952
945
937
937
Sales/Revenue/Turnover
1,192
1,416
1,642
2,181
2,315
2,400
2,190
2,955
2,830
3,172
3,364
3,737
- -
Operating Margin (%)
15.62
12.3
10.95
9.65
7.2
9.57
13.21
16.23
10.92
17
16.57
20.01
- -
Depreciation Expense
52
65
71
90
95
153
136
140
148
146
139
149
- -
Net Income, GAAP
120
82
101
155
85
162
108
361
220
404
408
597
- -
Effective Tax Rate (%)
25.19
38.31
32.69
21.91
30.05
20.57
13.33
22.35
23.99
21.08
22.8
20.84
- -
Profit Margin (%)
10.08
5.79
6.18
7.12
3.69
6.73
4.92
12.21
7.79
12.74
12.13
15.98
- -
Working Capital
202
1,036
372
397
654
546
789
727
736
1,016
1,170
1,253
1,253
LT Debt
221
544
430
447
779
841
796
612
657
742
757
536
536
Total Equity
551
1,788
1,822
2,105
1,992
2,022
2,257
2,359
2,334
2,643
2,726
3,296
3,296
Return on Invested Capital (%)
- -
6.36
4.91
6.19
4.12
6.24
3.83
11.27
7.25
12.67
11.93
15.5
- -
Return on Capital (%)
- -
6.25
4.73
6.48
4.39
6.51
4.24
11.64
7.57
13.24
12.56
16.31
- -
Return on Common Equity (%)
- -
7.05
5.65
7.94
4.17
8.04
5.05
15.7
9.44
16.32
15.26
19.88
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
167
113
118
LT Borrowings
621
511
407
LT Finance Leases
136
144
129
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
942
937
935
Market Capitalization
- -
3,899
4,956

Working Capital

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
1,749
1,674
1,813
Cash, Cash Equivalents & STI
817
558
767
Accounts Receivable, Net
614
772
699
Inventories
169
192
204
Total Current Liabilities
578
538
560
Payables & Accruals
- -
- -
- -
ST Debt
167
113
118
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.59%
8.15%
20.91%
Free Cash Flow
708.97%
96.61%
87.97%
Net Income, GAAP
41.43%
65.3%
46.32%
Sales/Revenue/Turnover
10.98%
11.98%
11.07%
Total Cash Common Dividend
84.71%
165.7%
15.96%

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
3,172
2024
- -
- -
3,364
2025
- -
- -
3,737

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.42
2024
- -
- -
0.43
2025
- -
- -
0.64

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.1
2024
- -
- -
0.17
2025
- -
- -
0.2

Company Description

Company Profile APIChatGPT
CEO
Yik Long Chan
Full Time Employees
8,538
Sector
Health technology
Industry
Medical specialties
Address
CEO Tower Hong Kong Hong Kong
IPO Date
Dec 15, 2015
Website
moderndentalgp.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Modern Dental Group Limited, operating as an investment holding entity, specializes in the global production and distribution of custom dental prosthetic solutions across key markets including Europe, Greater China, North America, and Australia. The company structures its diverse offerings into three principal segments: Fixed Prosthetic Devices, Removable Prosthetic Devices, and a comprehensive Others category. The Fixed Prosthetic Devices segment encompasses restorative options like crowns, bridges crafted from various materials including metal-ceramic and metal-free compositions, alongside custom implant solutions that are permanently bonded within the patient's mouth. In contrast, the Removable Prosthetic Devices segment focuses on manufacturing complete and partial dentures, available with or without metal frameworks. The expansive Others segment delivers a variety of products such as orthodontic appliances, encompassing clear aligners like TrioClear™, protective sports guards, and specialized anti-snoring devices. This segment also supplies essential raw materials, advanced dental equipment, including intra-oral scanners, and provides valuable services through educational events and professional seminars for dental practitioners. Modern Dental Group serves an extensive client base of over 30,000 customers globally, including dentists, clinics, hospitals, and distributors. The company leverages a portfolio of recognized brands such as Labocast, Permadental, Elysee Dental, Yangzhijing, Modern Dental Laboratory, Southern Cross Dental, Modern Dental USA, Apex Digital Dental, and TrioClear™. Recent strategic developments include the January 2025 acquisition of Hexa Ceram, Thailand's largest dental laboratory, which has expanded its market presence and product capabilities, and the 2025 acquisition of Digital Sleep Design to bolster its anti-snoring device offerings. Modern Dental Group has demonstrated robust financial performance, reporting record revenues and a significant increase in net profit for the first half of 2025, driven by organic growth, enhanced operational efficiency through digital solutions, and strategic acquisitions. The company, founded in 1986, maintains its headquarters in Hong Kong.